Here, we performed a prospective, investigator-initiated, cross-sectional, monocentric study to evaluate the non-invasive prediction of IDH mutation status in glioma patients using standard single voxel 1H-MRS. The gene discussed is IDH2; the disease is central nervous system cancer.